Nonablative neonatal bone marrow transplantation rapidly reverses severe murine osteopetrosis despite low-level engraftment and lack of selective expansion of the osteoclastic lineage

Journal of Bone and Mineral Research

Volumn 25, Issue 9, 2010, Pages 2069-2077

  Flores, Carmen ^a   De Vries, Teun J ^b   Moscatelli, Ilana ^a   Askmyr, Maria ^a   Schoenmaker, Ton ^b   Langenbach, Geerling E J ^b   Ehinger, Mats ^c   Everts, Vincent ^b   Richter, Johan ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone marrow; Cellular therapy; Hematopoietic stem cells; Osteoclasts; Osteopetrosis; Transplantation

Indexed keywords

COLONY STIMULATING FACTOR 1; OSTEOCLAST DIFFERENTIATION FACTOR;

ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL EXPANSION; CELL SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENGRAFTMENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; MOUSE; NEWBORN; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PROTEIN EXPRESSION;

ANIMALS; ANIMALS, NEWBORN; BONE MARROW TRANSPLANTATION; MICE; MICE, INBRED C3H; OSTEOCLASTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77956830716     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.90     Document Type: Article

References (28)

1. Buckley RH, Schiff SE, Schiff RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999;340:508-516. (Pubitemid 29093286)
2. + cells in a patient with selective T-lymphocyte reconstitution after bone marrow transplantation for B-SCID. Blood. 1994;84:3584-3589.
3. van Leeuwen JE, van Tol MJ, Joosten AM, et al. Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency. Blood. 1994;84:3936-3947.
4. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 2000;288:669-672. (Pubitemid 30241569)
5. + cells in ADA-deficient SCID neonates. Nat Med. 1998;4:775-780.
6. Aiuti A, Slavin S, Aker M, et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2002;296:2410-2413.
7. Ott MG, Schmidt M, Schwarzwaelder K, et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med. 2006;12:401-409.
8. Askmyr MK, Fasth A, Richter J. Towards a better understanding and new therapeutics of osteopetrosis. Br J Haematol. 2008;140:597-609.
9. Fasth A, Porras O. Human malignant osteopetrosis: pathophysiology, management and the role of bone marrow transplantation. Pediatr Transplant. 1999;3(Suppl 1):102-107.
10. Kornak U, Schulz A, Friedrich W, et al. Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum Mol Genet. 2000;9:2059-2063.
11. Frattini A, Blair HC, Sacco MG, et al. Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero. Proc Natl Acad Sci U S A. 2005;102:14629-14634.
12. Tondelli B, Blair HC, Guerrini M, et al. Fetal liver cells transplanted in utero rescue the osteopetrotic phenotype in the oc/oc mouse. Am J Pathol. 2009;174:727-735.
13. Askmyr M, Holmberg J, Flores C, Ehinger M, Hjalt T, Richter J. Low-dose busulphan conditioning and neonatal stem cell transplantation preserves vision and restores hematopoiesis in severe murine osteopetrosis. Exp Hematol. 2009;37:302-308.
14. Johansson M, Jansson L, Ehinger M, Fasth A, Karlsson S, Richter J. Neonatal hematopoietic stem cell transplantation cures oc/oc mice from osteopetrosis. Exp Hematol. 2006;34:242-249. (Pubitemid 43184329)
15. Johansson MK, de Vries TJ, Schoenmaker T, et al. Hematopoietic stem cell-targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc/oc mice. Blood. 2007;109:5178-5185.
16. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 1997;407:313-319.
17. Sands MS, Barker JE. Percutaneous intravenous injection in neonatal mice. Lab Anim Sci. 1999;49:328-330.
18. Thaung C, Arnold K, Jackson IJ, Coffey PJ. Presence of visual head tracking differentiates normal sighted from retinal degenerate mice. Neurosci Lett. 2002;325:21-24.
19. Blin-Wakkach C, Wakkach A, Sexton PM, Rochet N, Carle GF. Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosis. Leukemia. 2004;18:1505-1511.
20. Wakkach A, Mansour A, Dacquin R, et al. Bone marrow microenvironment controls the in vivo differentiation of murine dendritic cells into osteoclasts. Blood. 2008;112:5074-5083.
21. Li P, Schwarz EM, O'Keefe RJ, et al. Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice. Arthritis Rheum. 2004;50:265-276.
22. Yao Z, Li P, Zhang Q, et al. Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression. J Biol Chem. 2006;281:11846-11855.
23. Cappariello A, Concetta Berardi, Peruzzi A, et al. Colonize the Bone and Improve the Phenotype of a Mouse Model of Autosomal Recessive Osteopetrosis. J Bone Miner Res. 2009; Published online July 15, DOI: 10.1359/JBMR.090715.
24. Soper BW, Lessard MD, Vogler CA, et al. Nonablative neonatal marrow transplantation attenuates functional and physical defects of beta-glucuronidase deficiency. Blood. 2001;97:1498-1504.
25. Carbonaro DA, Jin X, Cotoi D, et al. Neonatal bone marrow transplantation of ADA-deficient SCID mice results in immunologic reconstitution despite low levels of engraftment and an absence of selective donor T lymphoid expansion. Blood. 2008;111:5745-5754.
26. Coccia PF, Krivit W, Cervenka J, et al. Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med. 1980;302:701-708. (Pubitemid 10132096)
27. Karsdal MA, Martin TJ, Bollerslev J, Christiansen C, Henriksen K. Are nonresorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res. 2007;22:487-494.
28. Askmyr M, Flores C, Fasth A, Richter J. Prospects for gene therapy of osteopetrosis. Curr Gene Ther. 2009;9:150-159.